# An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

> **NCT01831960** · PHASE2 · COMPLETED · sponsor: **Intrepid Therapeutics, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** cortexolone 17α-propionate

## Key facts

- **NCT ID:** NCT01831960
- **Lead sponsor:** Intrepid Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831960, "An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01831960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*